The Continuing Tale of HIV and Cancer - PowerPoint PPT Presentation

1 / 13
About This Presentation
Title:

The Continuing Tale of HIV and Cancer

Description:

... Volberding, MD, at 12th Annual Ryan White HIV/AIDS Program Clinical Conference, IAS USA. ... MD, at 12th Annual Ryan White HIV/AIDS Program Clinical ... – PowerPoint PPT presentation

Number of Views:158
Avg rating:3.0/5.0
Slides: 14
Provided by: paulvol
Category:

less

Transcript and Presenter's Notes

Title: The Continuing Tale of HIV and Cancer


1

The Newer Face of Cancer in HIV Care
Paul A. VolberdingMarvin Sleisenger Professor of
MedicineUniversity of California San Francisco
From PA Volberding, MD, at 12th Annual Ryan
White HIV/AIDS Program Clinical Conference,
IASUSA.
2
Content Outline
  • Cancers beyond AIDS defining
  • Epidemiology Which one you might expect to see
  • Screening Does HIV affect your usual care?
  • (Management)
  • Prevention

3
HIV and CancersOne Approach to Relationships
  • Cancers caused by HIV
  • Cancers associated with condition/situation that
    lead to HIV infection
  • Cancers not related to HIV but occurring in
    HIV-infected

4
Cancers Directly Linked to HIV
  • Kaposis sarcoma
  • Non-Hodgkins lymphoma
  • CNS lymphoma
  • Typically have a much stronger incidence rise in
    HIV infected population, close connection to CD4
    decline.
  • Often linked to second infection

5
AIDS-Defining Cancers Have Dramatic Incidence
in HIV
Goedert J. Semin Oncol. 20004390-401.
6
Most Cancer in HIV is Infection Related
  • True for both AIDS and non-AIDS defining cancers
  • HPV (anal, cervical, etc), HBV (liver cancer),
    EBV (Hodgkins lymphoma, etc), H. pylori
    (gastric)
  • Much weaker association of HIV with cancers not
    known caused by second infection
  • Lung, renal, melanoma, prostate, etc

Kaiser-Permanente Cohort Silverberg et al CROI
2009 30
7
Hodgkins Disease
  • Association with HIV infection
  • Hodgkins disease RR 5 to 30
  • Non-Hodgkins disease RR 24 to 165
  • Patients with HIV present with
  • B symptoms (70 to 96), worse histology,
    higher-stage tumor (74 to 92 are III or IV),
    bone marrow involvement (40 to 50),
    pancytopenia
  • Good response to MOPP/ABV
  • Complete response 74.5
  • 2-year disease-free survival 62
  • Early better results with Stanford V and BEACOPP

Gerard L, et al. AIDS. 20031781-87.
8
Anogenital Cancers
  • Invasive cervical carcinoma
  • Considered an AIDS-defining condition
  • Anal cancer1
  • Not AIDS defining but very common
  • HPV involvement1-2
  • Both derive from premalignant dysplastic lesions
    due to HPV
  • Most oncogenic strains 16, 18, 31, 33, 35, 45
  • Repeated infections and infection with multiple
    HPV strains increase the risk of developing
    neoplasia

1Phelps RM, et al. Int J Cancer.
200194753-757. 2Martin F, et al. Sex Transm
Infect. 200177327-331.
9
HIV, Aging, and Cancer
  • Subject of increasing concern
  • As HIV cohort ages, will enter expected period of
    cancer risk
  • Also concern that cancer may be increased by
  • Chronic poorly characterized immune deficits
  • Chronic immune activation and inflammation of HIV
    replication
  • Oncogenic potential of long-term ARV exposure

10
Cancer ScreeningRecommendations of US Preventive
Services Task Force
  • Colorectal cancer
  • Breast cancer
  • Prostate cancer
  • Taken from Primary Care of Veterans with HIV

11
Cervical Cancer Screening
  • Pap smear or liquid-based cytology in sexually
    active women with a cervix
  • Start at age 21 or within 3 years of sexual
    activity
  • In HIV-, screen every 3 years
  • In HIV, screen at HIV diagnosis and in 6 months
  • If neg. and CD4gt200, repaet annually
  • If neg. and CD4lt200, repeat every 6 months
  • Also screen for anal cancer annually with Pap
    smear

12
Anal Cancer Screening
  • Anal cancer increased in MSM population
  • No firm evidence based recommendation
  • Anal pap smears should be considered if available
  • No clear guidance on optimal follow-up management

13
Prostate Cancer Screening
  • Controversial. Some groups do, others dont
    recommend screening
  • If screen (ACS, AUA) annual after age 50 years
    with DRE and PSA
  • HIV men if anything at lower prostate cancer risk
Write a Comment
User Comments (0)
About PowerShow.com